[1]
J. Alijotas-Reig, E. Esteve-Valverde, D. Ruiz-Hidalgo, G. López-Sánchez, J. Trapé-Pujol, and F. Miró-Mur, “Anakinra as Rescue Therapy to Treat Patients with Severe COVID-19 Refractory to Tocilizumab”, acbr, vol. 5, no. 6, pp. 972–982, Dec. 2021.